Abstract
Burkholderia mallei and Burkholderia pseudomallei are potentially lethal pathogens categorized as biothreat agents due, in part, to their ability to be disseminated via aerosol. There are no protective vaccines against these pathogens and treatment options are limited and cumbersome. Since disease severity is greatest when these agents are inhaled, efforts to develop pre- or post-exposure prophylaxis focus largely on inhalation models of infection. Here, we demonstrate a non-invasive and technically simple method for affecting the inhalational challenge of BALB/c mice with B. pseudomallei and B. mallei. In this model, two investigators utilized common laboratory tools such as forceps and a micropipette to conduct and characterize an effective and reproducible inhalational challenge of BALB/c mice with B. mallei and B. pseudomallei. Challenge by oropharyngeal aspiration resulted in acute disease. Additionally, 50% endpoints for B. pseudomallei K96243 and B. mallei ATCC 23344 were nearly identical to published aerosol challenge methods. Furthermore, the pathogens disseminated to all major organs typically targeted by these agents where they proliferated. The pro-inflammatory cytokine production in the proximal and peripheral fluids demonstrated a rapid and robust immune response comparable to previously described murine and human studies. These observations demonstrate that OA is a viable alternative to aerosol exposure.
Highlights
The genus Burkholderia is comprised of numerous infectious species including Burkholderia pseudomallei and Burkholderia mallei
Oropharyngeal aspiration is an effective method for inhalational challenge of BALB/c mice with pathogenic Burkholderia species
Five 10-fold serial dilutions of challenge doses were administered by oropharyngeal aspiration (OA) to BALB/c mice
Summary
The genus Burkholderia is comprised of numerous infectious species including Burkholderia pseudomallei and Burkholderia mallei. Oropharyngeal Aspiration of B. pseudomallei and B. mallei in Mice sporadically endemic throughout the world between the 20th North and South Parallels but ‘‘hyper-endemic’’ in South East Asia as well as Australia’s Northern Territory [3] In these areas melioidosis is one of the most common causes of sepsis and severe community acquired pneumonia [4,5,6,7]. Glanders has a 95% mortality rate in untreated individuals, which improves to only 50% in treated patients [13] Both B. mallei and B. pseudomallei are considered potential biothreat agents and as such are ranked as Tier 1 Select Agents by the Centers for Disease Control and Prevention (CDC) [16]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.